Corporate Banner
Satellite Banner
Technology Networks Header
Sunday, December 21, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
New Syringe Pump Enhanced for Glucose Clamp Studies
Saturday, May 10, 2014
New Pump 11 Elite Glucose Clamp Infusion System from Harvard.

Researchers from the Département Environnement et Agro-biotechnologies at the CRP
Saturday, May 10, 2014
Gabriel Lippmann in Luxembourg use Nanoparticle Tracking Analysis for toxicology studies.

Agilent Introduces Cary 8454 UV Dissolution System
Tuesday, May 06, 2014
Next-generation diode array UV dissolution system for the pharmaceutical industry.

Cotton Rat Influenza Model Launched by Noble Life Sciences
Wednesday, April 23, 2014
New cotton rat model for preclinical studies of influenza therapies and vaccines.

New XFe96 Spheroid Microplate from Seahorse Bioscience
Tuesday, April 22, 2014
The microplate enables functional, metabolic measurement of in vitro tumor spheroids.

ERT Introduces GE Healthcare’s QT Guard Plus™ Analysis System
Friday, April 11, 2014
Novel approach may help to prevent false positive cardiac safety findings in new drug development.

New Metrohm Brochure and Website Pharmaceutical Analysis
Tuesday, April 08, 2014
Metrohm’s new brochure Pharmaceutical analysis is a highly valuable compendium to get an overall view of the most important parameters determining the quality of pharmaceuticals and the methods best suited to check them.

Hepregen Launches First Human HepatoPac™ Assay Kit
Wednesday, March 26, 2014
Application-directed kit provides information useful in predicting potential drug-induced liver injury.

Optibrium and Integrated Chemistry Design Collaborate
Tuesday, March 25, 2014
Asteris for iPad enables drug discovery scientists to quickly explore high quality compound ideas.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 656
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
SELECTBIO
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn